Feedback / Questions
taladegib (ENV 101) - Endeavor BioMed
https://www.businesswire.com/news/home/20251103520715/en/Endeavor-BioMedicines-Receives-Priority-Medicines-PRIME-Designation-from-the-European-Medicines-Agency-for-Taladegib-ENV-101-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis
Nov 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next